Syeda Mahak Zahra Bokhari
Syeda Mahak Zahra Bokhari is an expert in Biochemistry at Queen Mary University of London (United Kingdom). Syeda Mahak Zahra Bokhari has authored 12 publications, the most recent in 2025. SLR score: 32 (community average: 125). How the SLR is computed.
LeadR Profile
Biochemistry
Subspecialties: Pharmacy - Oncology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2023 - 2026
Number : 12
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Expression of costimulatory molecule CD70 is prognostic in small cell lung cancer. PMID 40205178 — cells, lung, neoplasms, immunotherapy, lung neoplasms, small cell lung carcinoma | Cancer Immunol Immunother | 2025 | 0 |
| 288 (PB276): Ivermectin enhances the efficacy of modulated electro-hyperthermia in a triple-negative breast cancer mouse model OpenAlex W4403748897 — triple negative breast neoplasms, ivermectin, breast neoplasms, hyperthermia, neoplasms, breast | Eur J Cancer | 2024 | 0 |
| Ivermectin Synergizes with Modulated Electro-hyperthermia and Improves Its Anticancer Effects in a Triple-Negative Breast Cancer Mouse Model. PMID 39144564 — triple negative breast neoplasms, ivermectin, breast neoplasms, hyperthermia, neoplasms, heat-shock proteins, breast, hsp27 heat-shock proteins, therapeutics | ACS Pharmacol Transl Sci | 2024 | 0 |
| Heat shock factor 1 inhibition enhances the effects of modulated electro hyperthermia in a triple negative breast cancer mouse model. PMID 38589452 — cells, up-regulation, genes, triple negative breast neoplasms, growth, breast neoplasms, hyperthermia, neoplasms, breast, natural science disciplines, therapeutics | Sci Rep | 2024 | 6 |
| Enhancing therapeutic efficacy in triple-negative breast cancer and melanoma: synergistic effects of modulated electro-hyperthermia (mEHT) with NSAIDs especially COX-2 inhibition in in vivo models. PMID 38217262 — melanoma, triple negative breast neoplasms, therapeutics, interleukin-1, cyclooxygenase 2 inhibitors, interleukin-6, anti-inflammatory agents, non-steroidal, aspirin, caspase 3, interleukin-1beta, hyperthermia | Mol Oncol | 2024 | 5 |
LeadR Networks
Main global connection map